跳至主要内容
临床试验/NCT06670430
NCT06670430
招募中
不适用

Digital Heath Integration With Neuromodulation Therapies on Sensory and Motor Function in Patients With Diabetic Neuropathy

Cairo University1 个研究点 分布在 1 个国家目标入组 60 人2024年11月10日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Diabetic Neuropathies
发起方
Cairo University
入组人数
60
试验地点
1
主要终点
nerve conduction velocity
状态
招募中
最后更新
去年

概览

简要总结

This study will be carried out on 60 patients both gender male and female with diabetic neuropathy with age55-65 years. The patients will be selected from Elmahmoudia hospital .patients will be randomly assigned to two groups.

详细描述

Experimental Group: This group will include 30 type II diabetic patients with peripheral neuropathy Patients will receive TENS and NMES for 30 minutes 3 days per week,for 10 weeks with medical treatment. Control Group: This group will include 30 type II diabetic patients with peripheral neuropathy Patients will receive placebo TENS and NMES for 30-min sessions, 3 days per week, for 10 weeks with medical treatment.

注册库
clinicaltrials.gov
开始日期
2024年11月10日
结束日期
2025年12月30日
最后更新
去年
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Principal Investigator
主要研究者

Alaa Mohamed Abdelaty Marzouk

demonstrator

Cairo University

入排标准

入选标准

  • Diagnosis of diabetes based on World Health Organization (WHO) with ages from 55to 65years
  • BMI\> 25kg/m2
  • Clinically diagnosed with diabetic neuropathy.
  • All patients are taking oral hypoglycemic drugs with controlled diabetes mellitus.
  • Willingness to comply with the study procedures and interventions.
  • Ability to provide informed consent.
  • presenting with Distal symmetric polyneuropathy (DSPN) based on a score of ≥7 on the validated Michigan Neuropathy Screening Instrument (MNSI) questionnaire.
  • exhibiting moderately controlled blood pressure

排除标准

  • Presence of other significant neurological or musculoskeletal disorders that may confound the assessment of outcomes.
  • Severe cognitive impairment or inability to provide informed consent.
  • Any recent surgical procedures or major medical events that could affect the study outcomes.
  • Heart Failure.
  • Uncooperative patients.
  • Anemic patient.
  • Patients with liver diseases.
  • Smokers Patients.
  • Any cardiac pacemaker, automatic implantable cardioverter defibrillator (AICD), or other implanted electrical device
  • An existing deep vein thrombosis (DVT)

结局指标

主要结局

nerve conduction velocity

时间窗: 10 weeks

Adhesive patches called surface electrodes are placed on the skin over nerves or muscles at different spots. A very mild electrical impulse is applied via other patches or a handheld stimulator to stimulate the nerve. The resulting electrical activity of the nerve is recorded by the electrodes. The distance between electrodes and the time it takes for electrical impulses to travel between electrodes are used to measure the speed of the nerve signals. It is normal for several different nerves to be tested.

Electromyography

时间窗: 10 weeks

An EMG evaluates the electrical activity a muscle produces at rest and when it contracts, similar to an EKG of the heart muscle. The doctor places a single, small, Teflon-coated wire pin into selected muscles to be studied. The tip of the pin acts like an antenna, picking up electrical activity from the muscle that can be heard and seen on a screen. You will be asked to tighten (contract) the muscle. Electrical activity is recorded and can be heard as popping and clicking sounds when the muscle is contracting

次要结局

  • Google Fit(10 weeks)
  • Manage My Pain(10 weeks)
  • PEDIS Score Diabetes App(10 weeks)

研究点 (1)

Loading locations...

相似试验